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Background. Typhoid fever is caused by Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) and can lead to sys-
temic illness and complications. We aimed to characterize typhoid-related ileal perforation in the context of the population-based 
Surveillance of Enteric Fever in Asia Project (SEAP) in Bangladesh, Nepal and Pakistan.
Methods. Between September 2016 and September 2019, all cases of nontraumatic ileal perforation with a clinical diagnosis 
of typhoid were enrolled from 4 tertiary care hospitals in Karachi, 2 pediatric hospitals in Bangladesh, and 2 hospitals in Nepal. 
Sociodemographic data were collected from patients or their caregivers, and clinical and outcome data were retrieved from medical 
records. Tissue samples were collected for histopathology and blood cultures where available.
Results. Of the 249 enrolled cases, 2 from Bangladesh, 5 from Nepal and 242 from Pakistan. In Pakistan, most of the cases 
were in the 0–15 (117/242; 48%) and 16–30 (89/242; 37%) age groups. In all countries, males were most affected: Pakistan 74.9% 
(180/242), Nepal 80% (4/5), and Bangladesh 100% (2/2). Blood culture was done on 76 cases; 8 (11%) were positive for S. Typhi, and 
all were extensively drug resistant (XDR) S. Typhi. Tissue cultures was done on 86 patients; 3 (3%) were positive for S. Typhi, and all 
were XDR S. Typhi, out of 86 samples tested for histopathology 4 (5%) revealed ileal perforation with necrosis. Culture or histopa-
thology confirmed total 15 (11%) enteric fever cases with ileal perforation are similar to the clinically diagnosed cases. There were 
16/242 (7%) deaths from Pakistan. Cases of ileal perforation who survived were more likely to have sought care before visiting the 
sentinel hospital (P = .009), visited any hospital for treatment (P = .013) compared to those who survived.
Conclusions. Although surveillance differed substantially by country, one reason for the higher number of ileal perforation 
cases in Pakistan could be the circulation of XDR strain of S. Typhi in Karachi.
Keywords.  enteric perforation; ileal perforation; Salmonella Typhi; enteric fever; typhoid fever.
Typhoid fever caused by Salmonella enterica subspecies enterica 
serovar Typhi (S. Typhi) can lead to systemic illness that has been 
a major source of morbidity and mortality in low-income commu-
nities [1]. Despite advancements in medical treatment, addressing 
typhoid fever remains difficult in many parts of the world such as 
South Asia, where poor water supply and sanitation remain a major 
problem [2, 3]. In such settings, incidence can be as high ≥10 cases 
per 100 000 population per year, and 1 in 5 children experiences 
typhoid infection by the age of 10 years [4, 5]. An important factor 
in decreasing the burden of typhoid fever has been the emergence 
of antibiotic resistance [6]. Multidrug resistant (MDR) strains of 
S. Typhi, resistant to ampicillin, trimethoprim-sulfamethoxazole 
(TMP-SMZ), and chloramphenicol have increased dramatically 
in the last 2 decades [7]. More recently, extensively drug resistant 
(XDR) strains have been isolated in Pakistan that are resistant to 
ampicillin, TMP-SMZ, fluoroquinolones, and third-generation 
cephalosporins, leaving limited treatment options for typhoid 
treatment [8]. Untreated typhoid disease can lead to altered mental 
states (termed the typhoid state), ileus, gastrointestinal bleeding, 
ileal perforation septic shock, and death [1, 9, 10]. Ileal perfora-
tion is a fatal complication that usually occurs in the second or 
third week of illness, due to inflammation and necrosis of Peyer’s 
patches. However, it has also been reported in the second week of 
illness in lower middle-income countries [11–14]. Typhoid related 
ileal perforation has been reported in 0.8%–39% of typhoid pa-
tients [15–17] with a higher incidence in low- and middle-income 
countries [18, 19]. Reported mortality rates due to ileal perforation 
range from 5% in wealthy regions to 80% in poor regions [20, 21]. 
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The burden of typhoid related ileal perforation has been attributed 
to these factors: increasing antibiotic resistance, delay in diagnosis, 
delay in surgical treatments, inappropriate surgical technique and 
nonavailability of guidelines for appropriate postoperative care 
[22]. The emergence of antimicrobial resistance, especially XDR 
strains of S. Typhi in Pakistan, may increase the risk of typhoid 
perforation. The lack of availability of antimicrobial sensitivity 
testing and limited understanding of its importance in most sec-
ondary level hospitals and first level care facilities can increase the 
delay in initiating the appropriate course of antimicrobial therapy 
and increase the risk of treatment failures.
With worsening antimicrobial resistance, it is important to 
assess the burden and consequences of typhoid related ileal per-
foration. We aim to describe the frequency of typhoid related 
ileal perforation and attributed mortality from a multicenter, 
prospective surveillance project in 3 Asian countries.
METHODS
Study Design and Settings
This prospective surveillance study was part of the Surveillance 
for Enteric Fever in Asia Project (SEAP) conducted at dif-
ferent hospitals and lab networks in Bangladesh, Nepal,  and 
Pakistan from September 2016 to September 2019 [23]. For 
the enrollment of surgical cases in Bangladesh, the study was 
conducted in Dhaka Shishu (Children’s) Hospital and Shishu 
Shasthya Foundation Hospital. Both serve the pediatric popu-
lation. In Nepal the study was conducted in Dhulikhel Hospital 
and Kathmandu Medical College and Teaching Hospital, 
which serves both adult and pediatric population. In Pakistan 
we selected JinnahPostgraduate Medical Center (JPMC), 
the National Institute of Child Health (NICH), Aga Khan 
University Hospital (AKUH),and Kharadar General Hospital 
(KGH). These included bothpublic and private tertiary care 
facilities serving adults, pediatric populations, or both. All site 
hospitals public and private were purposefully selected to in-
clude patients with diverse socioeconomic background and 
logistical accessible. Enrollment of typhoid-related ileal per-
foration cases was initiated in September 2016 at AKUH and 
KGH, in November 2016 at NICH, and in February 2018 at 
JPMC. In Nepal and Bangladesh, the enrollment was started in 
September 2016 at all of their sites.
Eligibility Criteria
All hospitalized cases with a diagnosis of nontraumatic ileal 
perforation due to suspected typhoid were identified from 
the daily census sheets of the respective surgical units in the 
selected hospitals.
The diagnosis of typhoid perforation was made by the 
admitting surgeon and was mainly clinical, supplemented by 
intraoperative findings of acute, inflamed, terminal ileal perfo-
ration. Patients with ileal perforation due to tuberculosis and 
malignancy identified perioperatively or on subsequent tissue 
histopathology were excluded.
Enrollment and Data Collection
Trained research associates with nursing or medical background 
approached the patient under the supervision of a surgeon used 
a structured questionnaire to collect sociodemographic data 
through a face-to-face interview with either the adult patient or 
the caregiver of a child. The clinical diagnosis, surgical record, 
and outcome were obtained from the patients’ medical records. 
The medical records were reviewed daily to identify any change 
in the diagnosis. Close coordination and liaison were estab-
lished with all surgeons in the respective units of the selected 
hospitals. Detailed data on the sociodemographic and clinical 
characteristics was collected from all surgical enrolled patients 
from all countries. Information from the questionnaire and 
medical records was directly entered into the tablets. Follow-up 
of all patients was done through phone calls 6 weeks after en-
rollment. Information about outcome (survival/death) and re-
covery was collected during 6 week follow-up.
Data Management
The tablets’ electronic data collection system automatically 
assigned a unique identification number to the data of each 
participant. The research supervisor cross-checked each ques-
tionnaire for any errors or an inconsistent response at the end of 
the day before syncing the data into the central database.
Laboratory Testing and Procedures
After enrollment of the patient, blood culture was collected and 
then treatment was initiated. The trained research staff col-
lected 5–10 mL of the blood sample and submitted to clinical 
laboratory of AKUH for testing. During surgery, the operating 
surgeon obtained tissue samples in normal saline and provided 
them to the study staff for histopathology testing. The study 
staff delivered the tissue samples to the Infectious Diseases and 
Research Laboratory (IDRL) of Aga Khan University for cul-
ture and histopathology testing. Ultrasound or any other tests 
needed for the confirmation of the perforation were performed 
at the discretion of the operating surgeon.
Data Analysis
Data were retrieved directly from the server, and descriptive 
statistics were calculated for both continuous and categorical 
variables. For continuous variables, the mean with standard 
deviation were calculated. For categorical variables, frequency 
with percentages was calculated. Factor analysis of ileal perfo-
ration patients’ household possessions was performed to deter-
mine socioeconomic status (SES). Factors with high eigenvalues 
were considered to classify SES and generate scores. These 
were then divided into 3 quintiles. Trends of ileal perforation 
across different age groups were analyzed. A comparison of the 
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recovered versus those who died was analyzed. The number of 
ileal perforation across different age groups were plotted in a 
line graph, and comparison of the survivors versus nonsurvived 
was analyzed using Pearson χ 2 or Fisher exact test to calculate 
the P values. A P value of < .05 was considered statistically sig-
nificant. In order to evaluate whether culture or histopathology 
confirmed enteric fever cases with ileal perforation are similar 
to the clinically diagnosed cases, we performed a sensitivity 
analysis as reported in Supplementary Table 1. P values were 
calculated using χ 2 or Fisher exact test for categorical and inde-
pendent sample t test for quantitative variables.
Ethical Consideration
Trained research associates with nursing or medical back-
ground approached the patients and/or their attendants and 
informed consent and/or assent was sought before the enroll-
ment. We obtained written informed consent from all adult pa-
tients (age 18 years and above). For all patients aged < 11 years 
consent was taken from their parents or legal guardians. For 
patients aged 11–17 years, assent along with parental consent 
was also obtained. Each individual participant had the right 
to withdraw her/his consent at any time. Confidentiality was 
maintained by the assigning unique identifier number, and no 
personal identifying details such as name was obtained. The 
study was approved by the ethical review committees (ERC) of 
the Bangladesh Institute of Child Health, Nepal Health Research 
Council, Aga Khan University, National Bioethics committee 
(NBC) Pakistan and Stanford University.
RESULTS
During September 2016 to September 2019 a total of 249 pa-
tients with ileal perforation were enrolled: 242 from Pakistan, 
2 cases from Bangladesh, and 5 from Nepal. In all 3 coun-
tries males were most affected: Pakistan 180/242 (74.9 %); 
Bangladesh 2/2 (100%); and Nepal 4/5 (80%). In Pakistan, 54% 
(130/242) of typhoid related ileal perforation were enrolled 
during 2018 and 30% in 2019 (73/242). Of the typhoid-related 
ileal perforation cases 41% (99/242) were in the first SES quin-
tile, and 39% (94/242) were in the third quintile (Table 1).
The median (interquartile range [IQR]) duration of illness 
prior to hospitalization was 11 (6, 18) days, and the duration 
of hospitalization was 8 (6, 13)  days. Fever, abdominal pain, 
constipation/diarrhea, and vomiting were the common clinical 
characteristics of the patients: 91% (219/242) sought care prior 
to hospitalization and 58% (142/242) self-reported that they 
had received an antibiotic before presenting to the hospital. 
Blood culture was done on 76 cases; 8 (11%) were positive for S. 
Typhi and all were XDR S. Typhi. Tissue culture was done on 86 
patients; 3 (3%) were positive for S. Typhi, and all were XDR S. 
Typhi. Culture or histopathology confirmed 15 (11%) ileal per-
foration cases were statistically similar to clinically diagnosed 
ileal perforations in terms of sociodemographic characteristics, 
clinical symptoms at the time of presentation, and final outcome 
at discharge. Only the occurrence of 1 or more clinical symp-
toms was statistically significant (Supplementary Table 1). Of 
the typhoid related ileal perforation cases from Pakistan, there 
were 16/242 (7%) deaths; 10 were aged 0–15 years. Among re-
covered patients, the median and IQR of the duration of illness 
prior to hospitalization was 11 (6, 17); of those who died it was 
15 (10, 28) days.
Cases of typhoid related ileal perforation who recovered as 
compared to those who died were more likely to seek care be-
fore visiting the sentinel hospital (92% vs 69%; P =  .009) and 
more likely to visit other hospitals for treatment (68% vs 63%; 
P  =  .013). No other significant difference in terms of clinical 
or sociodemographic characteristics between the two groups 
were identified (Table  2). The frequency of ileal perforation 
was highest in all age groups in 2018, followed by 2019 and 
2017. The pattern of typhoid related ileal perforation was sim-
ilar in 2018 and 2019, with highest frequency in the age group 
15–25 followed by 5–10 years old; however, in 2017 the highest 
number of ileal perforation occurred among 5–10 years old age 
group only (Figure 1).
DISCUSSION
We conducted surveillance in three large cities in Bangladesh, 
Nepal, and Pakistan for ileal perforation. The surveillance in 
Karachi included 2 additional hospitals specifically to look for 
perforations. Compared with Bangladesh and Nepal, we ob-
served more ileal perforation cases in Pakistan, at a time when 
there was widespread circulation of XDR typhoid. Due to the un-
availability of sensitive tool for the diagnosis of typhoid-related 
ileal perforation, in this study all cases were diagnosed based 
on intraoperative findings supplemented with clinical sign and 
symptoms. Blood cultures were sent by the treating physicians 
in only a small proportion of the cases; the tissue samples either 
were not collected at the time of surgery, or tissue samples were 
collected in formalin hindering culture. Only a minority cases 
of ileal perforation were confirmed through blood and tissue 
cultures and histopathology testing. Traditionally, diagnosis is 
made mainly on the basis of clinical history and examination, 
X-ray abdomen, and ultrasound abdomen. Although serologic 
and bacteriologic data may be supportive, these are frequently 
negative. Blood cultures are positive for S. Typhi in only 3–34% 
of cases of typhoid perforation, and cultures of the stool and 
peritoneal fluid are usually negative for this organism [24]. 
Although surgical diagnosis of typhoid related ileal perforation 
is not 100% sensitive or specific, this is the most frequently re-
ported method for the diagnosis of typhoid-related ileal per-
foration in the existing literature. Most of the earlier studies 
reported from African countries were based on confirmation 
on Widal test or clinical suspicion, which is known to have poor 
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sensitivity and specificity [25–28]. Polymerase chain reaction 
(PCR) based testing and immunohistochemical staining of the 
tissue as a tool for diagnosis of typhoid-related ileal perforation 
is currently under investigation and might improve the diag-
nosis in future.
Differences in the surveillance sites could partly explain 
the high number of cases from Pakistan. Although the SEAP 
surveillance sites were used to enroll ileal perforation cases 
from Bangladesh and Nepal, in Pakistan (in addition to the 
SEAP surveillance sites) 2 additional public sector tertiary 
care referral hospitals were used. Being public sector referral 
hospitals, patients were from lower socioeconomic back-
grounds and also from the very remote areas of Sindh prov-
ince. Another contributing explanation to the larger number 
of cases in Pakistan could be the difference in antibiotic re-
sistance patterns, especially XDR strains of S. Typhi in the 3 
countries. Pakistan is the only country among the SEAP sites 
where XDR typhoid fever is prevalent Yousafzai et al Pakistan 
budren paper in this supplement (S214). In addition, the mi-
nority of the blood samples from the patients with ileal per-
foration from Pakistan from which S. Typhi were isolated, 
all were XDR. Therefore, a higher proportion of XDR ty-
phoid cases in Pakistan might have contributed to the higher 
number of typhoid-related ileal perforation. Whether the 
higher number of ileal perforation cases in Pakistan as com-
pared to the other 2 countries is the function of XDR outbreak 
Table 1.  Sociodemographic and Clinical Characteristics of Patients 
With Enteric Perforation in Pakistan, Nepal, and Bangladesh, Surveillance 
for Enteric Fever in Asia Project (SEAP), 2016–2019 (N = 249)
Sociodemographic Variables Pakistan Nepal Bangladesh
 N = 242 (%) N = 5 (%) N = 2 (%)
Age in years    
 0–15 117 (48) 1 (20) 2 (100)
 16–30 89 (37) 1 (20) 0 (0)
 >30  36 (15) 3 (60) 0 (0)
Sex    
 Male 180 (75) 4 (80) 2 (100)
    
 Clinical characteristics Median (IQR)   
 Duration of illness before  
hospitalization
11 (6,18)   
 Duration of hospitalization 8 (6,13)   
 Fever 234 (97)   
 Abdominal pain 224 (93)   
 Constipation/diarrhea 137 (57)   
 Vomiting 148 (61)   
Health-seeking behavior    
 Patient sought any care from  
somewhere else before  
enrollment visit 
219 (91)   
 Treatment from any hospital 163 (67)   
 Treatment from pharmacy,  
clinic or physician
134 (55)   
 Received treatment from  
traditional healer
10 (4)   
Prior treatment  N = 208   
 Antibiotic 141 (58)   
 Antipyretic 194 (80)   
 Analgesic 123 (51)   
 Antidiarrheal 16 (7)   
Patients receiving antibiotics  
during hospitalization
N = 236 (%)   
 Type of antibiotics    
 Cephalosporin 86 (36)   
 Piperacillin and tazobactam 23 (10)   
 Ciprofloxacin 34 (14)   
 Metronidazole 33 (14)   
 Carbapenem 34 (14)   
 Other 26 (11)   
Chest X-ray N = 242 (%)   
 Performed 177 (73)   
 Indicated but not performed/ 
missing/not indicated
65 (27)   
Abdominal ultrasound finding N = 146 (%)   
 Internal bleeding/intestinal  
hemorrhage 
17 (12)   
 Intestinal perforation 114 (78)   
 Hepatomegaly/splenomegaly 23 (16)   
 Peritonitis 70 (48)   
 Other 54 (37)   
Blood culture positive for S. Typhi 8/76 (11)  1/3 (33)  
MDR 0  0  
XDR 8 (100)  0  
Tissue culture N = 86 (%)   
 NICH 57 (66)   
 JPMC 29 (34)   
Sociodemographic Variables Pakistan Nepal Bangladesh
 N = 242 (%) N = 5 (%) N = 2 (%)
 Tissue culture positive for S. Typhi 3 (3)   
 Histopathology confirmed Ileal  
perforation with necrosis
4 (5)   
 Blood/ tissue culture/ histopathology 
positive for S. Typhi (individuals)
15/131 (11)   
Hospital where surgery performed N = 242 (%)   
 AKUH/KGH 19 (8)   
  NICH 103 (42)   
 JPMC 120 (50)   
Final outcome at discharge N = 242 (%) n = 5 (%) n = 2 (%)
 Recovered 226 (93) 5 (100) 2 (100)
 Died 16 (7) 0 (0) 0 (0)
Social and economic status    
Wealth status scores (tertile) N = 242 (%)   
 Low wealth status 99 (41)   
 Medium wealth status 49 (20)   
 High wealth status 94 (39)   
Year of surveillance N = 242 (%)   
 2016 4 (2)   
 2017 35 (14)   
 2018 130 (54)   
 2019 73 (30)   
Abbreviations: AKUH, Aga Khan University Hospital; JPMC, Jinnah Postgraduate Medical 
Center; IQR, interquartile range; KGH, Kharadar General Hospital; MDR, multidrug re-
sistant; NICH, National Institute of Child Health; XDR, extensively drug resistant.
Table 1. Continued
S236 • cid 2020:71 (Suppl 3) • Qazi et al
of Salmonella Typhi in Pakistan or just the reflection of how 
and where the surveillance was conducted in these 3 coun-
tries is hard to conclude [29]. A 2-year surveillance study in 
Tanzania during 2006–2008 enrolled 104 typhoid-related 
ileal perforation cases. The study reported male preponder-
ance and higher incidence in the age group 11–20 years old 
[26]. In contrast, a study from India during 2015–2017, re-
ported higher proportions of typhoid-related ileal perfora-
tion among adults aged 31–40 years [30]. Nonetheless, males 
being at higher risk of typhoid-related ileal perforation is 
consistent with reports from India and several other coun-
tries [31, 32]. Only 1 study from Nigeria reported a higher 
number of ileal perforation cases among female populations 
[33]. The exact mechanism behind male preponderance for 
ileal perforation is not known. However, there might be a 
genetic predisposition among males that heightens the risk 
of ileal perforation [34]. Another reason could be the higher 
proportion of culture confirmed typhoid cases among the 
male population as compared to females. SEAP data from 
Pakistan showed significantly higher proportion of culture 
confirmed typhoid among the male population Yousafzai et 
al paper in this supplement.
In this study, the duration of illness among patients with ileal 
perforation was >10 days before hospitalization. Typhoid-related 
Table 2. Comparison of Patients With Enteric Perforation Who Died 
Versus Those Who Survived in Pakistan, Surveillance for Enteric Fever in 
Asia Project (SEAP), 2016–2019
Sociodemographic Variables Recovered Died P value
 N = 226 (%) N = 16 (%)  
Age in years    
 0–15 107 (48) 10 (62) .035
 16–30 87 (38) 2 (13)
 >30 32 (14) 4 (25)
Sex    
 Male 171 (76) 9 (56) .086
 Female 55 (24) 7 (44)
    
Clinical characteristics Median (IQR) Median (IQR)  
 Duration of illness before  
hospitalization
11 (6,17) 15 (10,28) .635
 Duration of hospitalization 8 (6,13) 8 (4,19) .488
 N (%)   
 Fever 219 (97) 15 (94) .495
 Abdominal pain 208 (92) 16 (100) .502
 Constipation / diarrhea 123 (54) 14 (88) .010
 Vomiting 134 (59) 14 (88) .081
Health-seeking behavior    
 Patient sought any care from  
somewhere else before  
enrollment visit
208 (92) 11 (69) .009
 Received treatment from  
any hospital
153 (68) 10 (63) .013
 Received treatment from any  
pharmacy, clinic, and physician
125 (55) 9 (56) .942
 Received treatment from  
traditional healer
9 (4) 1 (6) .019
Prior treatment    
 Patient received antibiotic 132 (58) 9 (56) .338
 Patient received antipyretic  
and analgesic
185 (82) 12 (75) .496
 Patient received  
antidiarrheal prior
15 (7) 1 (6) .354
 Patients receiving antibiotics  
during hospitalization
221 (98) 15 (94) .164
Type of antibiotics    
 Cephalosporin 31 (14) 3 (20) .590
Piperacillin and tazobactam 79 (36) 7 (47) .575
 Ciprofloxacin 33 (15) 1 (7) .430
 Metronidazole 33 (15) 0 (0) .136
 Carbapenem 24 (11) 2 (13) .793
 Other 21 (10) 2 (13) .665
Chest X-ray N = 226 (%) N = 16 (%)  
 Performed 163 (72) 14 (88) .180
 Indicated, but not performed/ 
missing and not indicated
63 (28) 2 (12)
Abdominal ultrasound performed 136 (60.2) 10 (62.5) .854
Ultrasound finding    
 Internal bleeding/intestinal  
hemorrhage 
16 (12) 1 (10) .867
 Intestinal perforation 107 (79) 7 (70) .522
 Hepatomegaly and splenomegaly 20 (15) 3 (30) .200
 Peritonitis 67 (49) 3 (30) .239
Blood culture    
 S. Typhi 8 (11) 0 .426
Hospital where surgery performed N = 226 (%) N = 16 (%)  
Sociodemographic Variables Recovered Died P value
 N = 226 (%) N = 16 (%)  
 AKUH/KGH 19 (8) 0 (0) .247
 NICH 94 (42) 9 (56.3) .486
 JPMC 113 (50) 7 (43.8) .775
Social and economic status    
 Wealth status scores (tertile) N = 226 (%) N = 16 (%)  
 Low wealth status 92 (41) 7 (44) .723
 Medium wealth status 47 (21) 2 (13) 
 High wealth status 87 (38) 7 (44)
Abbreviations: AKUH, Aga Khan University Hospital; IQR, interquartile range; JPMC, Jinnah 



























Figure 1. Trend of ileal perforation across different age groups, Karachi, Pakistan, 
Surveillance for Enteric Fever in Asia Project (SEAP), 2016–2019.
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ileal perforation classically presents in the second week of illness, 
and hospitalization for typhoid-associated ileal perforation is 
normally long, ranging from 2 to 4 weeks. The duration of hos-
pitalization is dependent on the condition of the patient at the 
time of admission and postoperative complications [33, 35–37].
Studies from other countries also reported delayed presentation 
and poor socioeconomic status as an important predictor of en-
teric perforations and its associated mortality [22]. In this study, 
16 deaths (7%) were observed among typhoid-related ileal perfo-
ration in Pakistan. Duration of illness, socioeconomic status, and 
prior use of antibiotics was not associated with mortality. However, 
mortality was significantly higher among children (<15 years old). 
The reported mortality ranged from 4% in northern part of India 
to as high as 34% in parts of sub-Saharan Africa [33, 38]. Mortality 
associated with enteric perforations can be prevented with early 
diagnosis and treatment, access to surgical care, availability of 
better surgical facilities, trained surgeons, and prevention of post-
operative complications [39]. Unfortunately, limitations in health-
care in general and surgical care in particular is lacking in lower 
and middle-income countries and can result in delays in accessing 
care and subsequent peri- or postoperative mortalities [22].
Our study had several limitations; a larger number of cases 
were identified from Pakistan presumably because this was the 
only site that had 2 surgical units of large public sector hos-
pitals included as sentinel sites for enrollment. Only a subset 
of the cases could be confirmed through blood cultures and 
histopathological examination of the tissues, and hence some 
misclassification might have occurred. However, clinical sus-
picion of typhoid based on a history of fever for more than a 
week, followed by perforation was used as a criterion for clin-
ical suspicion of typhoid-related ileal perforation and the 
intraoperative findings of the surgeons verified the diagnosis. 
The absence of a sensitive tool to confirm typhoid-related ileal 
perforation might have resulted in some classification bias re-
sulting in over-estimation of cases in this study. However, the 
study team worked closely with the operating surgeons to min-
imize any bias in diagnosis. Patients with ileal perforation due 
to tuberculosis and malignancy identified perioperatively or on 
subsequent tissue histopathology were excluded. Patients with 
typhoid-related ileal perforation who presented as dead or who 
died immediately after reaching the emergency department of 
the respective hospitals and could not be operated or diagnosed 
were not accounted for in this study, and hence the case fatality 
rate might have been underestimated.
CONCLUSIONS
Cases of typhoid-related ileal perforation were identified 
mainly in Pakistan; however, because of lack of availability of 
sensitive diagnostic tools, a bacteriologic diagnosis was not pos-
sible in most cases. Early diagnosis and treatment are essential 
for adequate management of ileal perforation in typhoid en-
demic countries. The development of improved tools to specify 
the cause of intestinal perforation would permit better under-
standing and tracking of this important occasional consequence 
of Salmonella typhoid and paratyphoid infection.
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